Fermenta Biotech has announced upcoming investor interactions in Mumbai on December 8, 2025, involving one-to-one and group meetings with company officials. The discussions will cover the financial results for the half-year and the latest investor presentation, both already publicly available. The company clarified that no unpublished price sensitive information (UPSI) will be shared during these interactions, providing transparency to investors. These meetings offer a direct channel for investors to engage with the company regarding its recent performance.